Spero Therapeutics (SPRO) Payables (2016 - 2026)
Spero Therapeutics' Payables was $155,000 in Q2 2026, down 80.1% from $780,000 a year earlier and down 28.6% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Payables (2016 - 2026) Analysis & Trends
At the end of FY2025, Payables at Spero Therapeutics came in at $693,000, down 90.5% from FY2024.
- Payables shows a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
- In earlier years, Payables was $7.31 million in FY2024 (+430.2%), $1.38 million in FY2023 (+123.3%), $617,000 in FY2022 (-44.0%) and $1.1 million in FY2021 (-4.7%).
- The Q2 2026 figure marks the lowest quarterly Payables in data going back to Q4 2016.
- Compared with a year earlier, Payables has declined for six straight quarters, with growth averaging 54.2% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q3 2024 (growth of 452.1%); the worst was Q4 2025 (a decline of 90.5%).
- Per Business Quant data, SPRO's Payables in the three quarters before Q2 2026 was $217,000 (Q1 2026), $693,000 (Q4 2025) and $1.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Spero Therapeutics | 68.40 Mn | -127.38 Mn | - | 155,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 155,000.00 |
| Mar 31, 2026 | 217,000.00 |
| Dec 31, 2025 | 693,000.00 |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 780,000.00 |
| Mar 31, 2025 | 1.77 Mn |
| Dec 31, 2024 | 7.31 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 3.07 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 583,000.00 |
| Dec 31, 2022 | 617,000.00 |
| Sep 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 4.78 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 3.16 Mn |
API Access
Spero Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();